J. Scott Garland sold $607K of Enliven Therapeutics stock
By AlphaYouPublished Form 4
Garland J. Scott
Reporting filer
J. Scott Garland reported selling 13,000 shares of Enliven Therapeutics, Inc. for about $607K ($46.67 a share on average). Form 4 filed Oct 5, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 5, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Garland J. Scott | 2026-10-01 | M | Exercise or conversion | 13000 | 15.47 | 13,000 | 4 days | Filed terms
|
| Common Stock | Garland J. Scott | 2026-10-01 | S | Sale | 13000 | 46.6707 | 0 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Garland J. Scott | 2026-10-01 | M | Exercise or conversion | 13000 | 0 | 46,372 | 4 days | Filed terms
|
Common Stock
- Owner
- Garland J. Scott
- Date
- 2026-10-01
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 13000
- Price
- 15.47
- Following holdings
- 13,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 13000
- transaction Price Per Share: 15.47
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 13000
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Garland J. Scott
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 13000
- Price
- 46.6707
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 13000
- transaction Price Per Share: 46.6707
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
- nature Of Ownership:
Stock Option (right to buy) (derivative)
- Owner
- Garland J. Scott
- Date
- 2026-10-01
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 13000
- Price
- 0
- Following holdings
- 46,372
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 15.47
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 13000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2036-01-07
- underlying Security Title: Common Stock
- underlying Security Shares: 13000
- shares Owned Following Transaction: 46372
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Garland J. Scott: Director.
- F1: This transaction was executed in multiple trades at prices ranging from $46.62 to $46.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- F2: The option, originally for 59,372 shares, vests as to 1/36th of the shares on February 7, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.
Original sources
Prepared automatically from public filing data. Report a correction.